Help with some feedback on these questions

New Post Public Reply Private Reply Replies (1) Message Board
venetian88
520
New to the board and have a small (8,000 shares) position in IPIX. Love the potential here but I have a handful of questions and was hoping to get some feedback before bumping up my position this week:

1). If the news today on the SI number is so great relative to other candidates, why the lack of movement on the stock? I read the post a little while ago about the system holding it down but seems to me a great score is a great score. They did a press release with the great score. Regardless of it being potentially held down artificially, why wouldn't that score just speak for itself? If a small biotech has a cure for some type of cancer, it often explodes. Today's news just seems significant and it worries me that the stock didn't move at all.

2). Having been burned in a number of biotechs, where cash and burn is often a problem, just curious as to how they are funding operations right now. I read through their annual report and it looks like just issuing warrants or other classes of stock continually? Obvious this is a hero or zero play so cash may not matter at all because it either works and they'll have all the money they need and then some or they'll not survive. Thoughts on how they can drag this out long enough to get to the finish line? government grant I'd assume?

3) I have a sell order in for $30/share so no one can have any of it to short but any wild assed guess on what true effectiveness could look like for share price? I know there are 100 ways to extrapolate a future value (buyout, partnership, go it alone, etc) and then a random guess as to how many people worldwide would need the treatment. So let me ask it another way....what are you guys that seem to really know your stuff here think is a price you'd be happy with six months from now that's not far-fetched? Not "I'll not sell for less then $500/share" type stuff, just real answers that are educated guesses on value if B works for covid.

4). ALL things considered (politics, funding, trial results, getting beat to market, etc), what are some educated guesses on B being the real deal and this stock exploding? I'll take anything over 35% odds, be comfortable and add more to my position. Over 50% would be fantastic.

Thanks in advance! I will say that some of the posts on here are as legit as I've ever seen on a message board. I am not a medical expert but there are some highly educated and informed people on here that seem to have a good handle on things. A very convincing handle I'd say. Just don't want to have $5,000 +/- in this thing later this week if it's just wasting it with little to no chance.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 72

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 85

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 51

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Milwaukee County Contract Tests Wisconsin Labor Shift

Updated Category News Views 6

A unanimous first contract in a Milwaukee County department is not the sort of headline that rattles a trading screen, but it can tell you plenty about where the ground is moving. Public safety workers in the county Facilities Department have ratified their first agreement with Teamsters Local 344, according to the union. The vote matters less for any disclosed economic...

Continue Reading
Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 95

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 99

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 13

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 56

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
Boston Scientific Loads Debt Cannon for Penumbra Deal

Updated Category News Views 128

A Very Large Financing Cart Rolled Out Boston Scientific just put an enormous stack of paper into the market, and nobody should mistake this for routine housekeeping. The company priced $3.0 billion of U.S. dollar senior notes and €4.25 billion of euro notes, with proceeds earmarked chiefly for the cash portion of its proposed Penumbra acquisition, alongside cash on...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 0

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Eli Lilly's Short Interest Trends and Market Sentiment

Updated Category News Views 217

Eli Lilly's Short Interest Overview The short interest for Eli Lilly has noticeably risen by 14.71% since the last report. Currently, there are about 6.27 million shares that have been sold short, which accounts for roughly 0.78% of all regularly traded shares. At the present trading volume, analysts estimate that it would take around 2.41 days for traders to close out...

Continue Reading
Bluevua Expands Reach with Major Online Retailers

Updated Category News Views 21

An Ecommerce Splash for Water Purification Here we are, diving headfirst into yet another tale of market expansion. Bluevua, a name that's been making waves with its reverse osmosis (RO) systems, just secured a roster spot on some of the biggest online retail giants: Target.com, Lowes.com, and Walmart.com. Sure, not every trader is into the nitty-gritty of water...

Continue Reading
Building Products M&A Trends Indicate a Bright Future Ahead

Updated Category News Views 108

Building Products M&A Trends: A Bright Future Ahead The building products mergers and acquisitions (M&A) sector is on the verge of significant growth as we approach 2026. This promising trajectory is rooted in the optimism surrounding the long-term prospects of the U.S. housing market. An analysis provided by experts in the industry illustrates the resilient nature of...

Continue Reading
Recursion to Share Pivotal REC-4881 Data at DDW 2025 Event

Updated Category News Views 499

Recursion to Share Pivotal REC-4881 Data at DDW 2025 Event Recursion, a pioneering clinical stage TechBio company, is set to unveil groundbreaking preliminary data regarding REC-4881 during the prominent Digestive Disease Week (DDW) event in 2025. This gathering is critical as it showcases advancements in gastrointestinal medicine and research. The data will be...

Continue Reading
Reviving the Legend: Remus Bourbon's Babe Ruth Reserve 2025

Updated Category News Views 258

Reviving a Baseball Legend with Remus Bourbon Remus Bourbon is excited to introduce its latest release, the 2025 Babe Ruth Reserve. This special edition pays homage to Babe Ruth, an icon in the world of baseball known as the Sultan of Swat. With only 8,399 bottles available, this limited production truly captures the spirit of both the game and the whiskey-making...

Continue Reading